NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vitality Biopharma Inc (PINK: VBIO)

 
VBIO Technical Analysis
2.5
As on 13th Dec 2021 VBIO STOCK Price closed @ 0.34 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.19 & Strong Buy for SHORT-TERM with Stoploss of 0.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VBIOSTOCK Price

Open 0.28 Change Price %
High 0.34 1 Day 0.06 21.43
Low 0.28 1 Week 0.03 9.68
Close 0.34 1 Month 0.04 13.33
Volume 8120 1 Year 0.18 112.50
52 Week High 1.61 | 52 Week Low 0.06
 
PINK USA Most Active Stocks
CNNA 0.01 0.00%
AITX 0.01 0.00%
TXGE 1826.91 -1.55%
CAVR 0.01 %
ENZC 0.05 25.00%
OZSC 0.01 0.00%
DPLS 0.01 0.00%
WRFX 0.01 %
AMXVF 1.05 10.53%
AABB 0.03 0.00%
 
PINK USA Top Gainers Stocks
MKVNF 0.06 500.00%
WARGF 0.16 300.00%
TDCH 0.60 275.00%
SEAV 0.07 250.00%
LAAB 0.03 200.00%
ACFL 0.02 100.00%
TZPC 0.02 100.00%
TRRE 0.06 100.00%
SOLS 0.02 100.00%
SIZYF 0.02 100.00%
 
PINK USA Top Losers Stocks
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
EHITF 8.42 -98.77%
EHITF 8.42 -98.77%
FFVWF 0.01 -94.12%
GFDV 0.01 -88.89%
MINRF 0.05 -82.14%
KIRY 0.02 -80.00%
APVTW 0.01 -75.00%
ATMS 0.50 -73.54%
 
 
VBIO
Daily Charts
VBIO
Intraday Charts
Whats New @
Bazaartrend
VBIO
Free Analysis
 
VBIO Important Levels Intraday
RESISTANCE0.46
RESISTANCE0.42
RESISTANCE0.40
RESISTANCE0.37
SUPPORT0.31
SUPPORT0.28
SUPPORT0.26
SUPPORT0.22
 
VBIO Forecast May 2024
4th UP Forecast0.51
3rd UP Forecast0.46
2nd UP Forecast0.42
1st UP Forecast0.39
1st DOWN Forecast0.29
2nd DOWN Forecast0.26
3rd DOWN Forecast0.22
4th DOWN Forecast0.17
 
VBIO Weekly Forecast
4th UP Forecast0.44
3rd UP Forecast0.41
2nd UP Forecast0.39
1st UP Forecast0.37
1st DOWN Forecast0.31
2nd DOWN Forecast0.29
3rd DOWN Forecast0.27
4th DOWN Forecast0.24
 
VBIO Forecast2024
4th UP Forecast3.35
3rd UP Forecast2.38
2nd UP Forecast1.79
1st UP Forecast1.19
1st DOWN Forecast-0.51
2nd DOWN Forecast-1.11
3rd DOWN Forecast-1.7
4th DOWN Forecast-2.67
 
 
VBIO Other Details
Segment EQ
Market Capital 19773038.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VBIO Address
VBIO
 
VBIO Latest News
 
Your Comments and Response on Vitality Biopharma Inc
 
VBIO Business Profile
Vitality Biopharma, Inc. focuses on developing cannabinoid pharmaceutical prodrugs in the United States. The company produces approximately 25 novel cannabosides, including glycosylated tetrahydrocannabinol (THC), cannabidiol, cannabidivarin, and cannabinol. It is developing THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was incorporated in 2007 and is headquartered in Los Angeles, California. Address: 200 Park Avenue, Cleveland, OH, United States, 44122
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service